Sean McCutcheon Analyst PerformanceVice President, Biotechnology Equity Research at Raymond James FinancialSean McCutcheon is a stock analyst at Raymond James Financial in the healthcare sector, covering 11 publicly traded companies. Over the past year, Sean McCutcheon has issued 9 stock ratings, including strong buy and buy recommendations. While full access to Sean McCutcheon's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean McCutcheon's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings18 Last 2 YearsBuy Recommendations94.44% 17 Buy RatingsCompanies Covered11 Unique Companies Ratings Distribution18RatingsDistribution of strong buy, buy, hold, and sell ratings by Sean McCutcheon.RatingPercentageCount Strong Buy27.8%5 ratings Buy66.7%12 ratings Hold5.6%1 ratings Sell0.0%0 ratingsOut of 18 total stock ratings issued by Sean McCutcheon at Raymond James Financial, the majority (66.7%) have been Buy recommendations, followed by 27.8% Strong Buy and 5.6% Hold.Best & Worst CallsBest Call0000.0%RVMDSep 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%JANXJul 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ11 companiesSean McCutcheon, an analyst at Raymond James Financial, currently covers 11 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare11 companies100.0%Sean McCutcheon of Raymond James Financial specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY11 companies100.0% About Sean McCutcheonSean McCutcheon joined Raymond James in 2021 as an associate covering biotechnology. Prior to Raymond James he was a postdoctoral fellow in the Department of Neuroscience at Albert Einstein College of Medicine focused on neuro-oncology. Prior to that he received his Ph.D. in biomedical engineering from The City College of New York, developing microfluidics to interrogate cell communication in the context of bone homeostasis, and obtained his Bachelor of Science degree in materials science and engineering from The Ohio State University, graduating with honors. His research in cancer and bone biology prior to joining Wall Street resulted in eight authored or co-authored peer-reviewed publications.Follow on LinkedIn Sean McCutcheon's Ratings History at Raymond James Financial Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsXLOXilio Therapeutics10/21/2026Initiated Coverage$8.54$16.00Outperform$0.0000.00% ROIBBOTBridgeBio Oncology Therapeutics9/9/2026Lower Price Target$8.20$22.00Outperform$0.0000.00% ROIXNCRXencor9/1/2026Boost Price Target$27.26$46.00Strong-Buy$0.0000.00% ROIFTHSensei Biotherapeutics7/31/2026Initiated Coverage$28.82$56.00Outperform$0.0000.00% ROIENGNenGene5/8/2026Downgrade$1.72$4.00Outperform$0.0000.00% ROIENGNenGene3/9/2026Reiterated Rating$7.60$27.00Strong-Buy$0.0000.00% ROICMPXCompass Therapeutics3/5/2026Reiterated Rating$5.65Outperform$0.0000.00% ROIVIRVir Biotechnology2/24/2026Upgrade$7.43$19.00Strong-Buy$0.0000.00% ROICMPXCompass Therapeutics1/6/2026Reiterated Rating$4.84$9.00Outperform$0.0000.00% ROIRVMDRevolution Medicines10/17/2025Boost Price Target$55.73$76.00Strong-Buy$000.0000.00% ROIRVMDRevolution Medicines9/12/2025Initiated Coverage$46.24$72.00Strong-Buy$000.0000.00% ROIVIRVir Biotechnology7/11/2025Initiated Coverage$5.65Outperform$0.0000.00% ROIJANXJanux Therapeutics7/11/2025Initiated Coverage$25.61$65.00Outperform$00.0000.00% ROIVIRVir Biotechnology7/11/2025Upgrade$5.93$12.00Moderate Buy$0.0000.00% ROICMPXCompass Therapeutics7/1/2025Upgrade$2.60$9.00Outperform$0.0000.00% ROIBDTXBlack Diamond Therapeutics7/1/2025Upgrade$2.48$11.00Outperform$0.0000.00% ROIENGNenGene11/27/2024Initiated Coverage$8.60$23.00Outperform$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsRaymond James Financial Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
